Nuveen Dividend Value Fund I (FAQIX)
13.96
+0.23
(+1.68%)
USD |
May 02 2025
Key Stats
Customize
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 0.70% | 2.992B | 1.98% | 79.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -254.44M | 4.66% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term growth of capital and income. The Fund invests at least 80% of its net assets in equity securities. The Funds sub-adviser will invest in companies that it believes have the ability to pay above average dividends and finance expected growth and are trading at attractive valuations. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US Income |
| Peer Group | Equity Income Funds |
| Global Macro | Equity North America |
| US Macro | Equity Income Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Equity Income Funds |
| Fund Owner Firm Name | Nuveen |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
6
-811.88M
Peer Group Low
1.489B
Peer Group High
1 Year
% Rank:
69
-254.44M
-7.375B
Peer Group Low
11.13B
Peer Group High
3 Months
% Rank:
7
-2.410B
Peer Group Low
3.725B
Peer Group High
3 Years
% Rank:
79
-15.15B
Peer Group Low
26.43B
Peer Group High
6 Months
% Rank:
77
-4.413B
Peer Group Low
8.221B
Peer Group High
5 Years
% Rank:
76
-15.10B
Peer Group Low
42.46B
Peer Group High
YTD
% Rank:
47
-2.410B
Peer Group Low
4.551B
Peer Group High
10 Years
% Rank:
53
-27.37B
Peer Group Low
48.46B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of May 03, 2025.
Asset Allocation
As of March 31, 2025.
| Type | % Net |
|---|---|
| Cash | 0.60% |
| Stock | 99.40% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.00% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Philip Morris International Inc | 3.18% | 170.86 | 0.48% |
| UnitedHealth Group Inc | 3.03% | 399.29 | -0.35% |
| Wells Fargo & Co | 2.77% | 73.76 | 2.72% |
| AT&T Inc | 2.53% | 27.61 | -0.11% |
| Citigroup Inc | 2.51% | 70.55 | 3.54% |
| The Cigna Group | 2.28% | 334.96 | -0.07% |
| Abbott Laboratories | 2.17% | 132.82 | 1.48% |
| Southern Co | 2.14% | 91.04 | -0.46% |
| NextEra Energy Inc | 2.04% | 67.07 | 1.54% |
| Bristol-Myers Squibb Co | 2.03% | 50.56 | 1.91% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | 0.57% |
| Administration Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | -- |
| Available for RRSP | -- |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 100000.0 None |
| Minimum Subsequent Investment | 0.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term growth of capital and income. The Fund invests at least 80% of its net assets in equity securities. The Funds sub-adviser will invest in companies that it believes have the ability to pay above average dividends and finance expected growth and are trading at attractive valuations. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US Income |
| Peer Group | Equity Income Funds |
| Global Macro | Equity North America |
| US Macro | Equity Income Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Equity Income Funds |
| Fund Owner Firm Name | Nuveen |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (5-2-25) | 1.61% |
| 30-Day SEC Yield (3-31-25) | 1.38% |
| 7-Day SEC Yield | -- |
| Stock | |
| Weighted Average PE Ratio | 25.85 |
| Weighted Average Price to Sales Ratio | 4.227 |
| Weighted Average Price to Book Ratio | 4.125 |
| Weighted Median ROE | 16.32% |
| Weighted Median ROA | 5.61% |
| ROI (TTM) | 9.62% |
| Return on Investment (TTM) | 9.62% |
| Earning Yield | 0.0517 |
| LT Debt / Shareholders Equity | 0.9162 |
As of March 31, 2025
Growth Metrics
| EPS Growth (1Y) | 16.12% |
| EPS Growth (3Y) | 8.35% |
| EPS Growth (5Y) | 10.22% |
| Sales Growth (1Y) | 8.03% |
| Sales Growth (3Y) | 8.92% |
| Sales Growth (5Y) | 7.77% |
| Sales per Share Growth (1Y) | 7.97% |
| Sales per Share Growth (3Y) | 8.85% |
| Operating Cash Flow - Growth Ratge (3Y) | 7.16% |
As of March 31, 2025
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:FAQIX", "name") |
| Broad Asset Class: =YCI("M:FAQIX", "broad_asset_class") |
| Broad Category: =YCI("M:FAQIX", "broad_category_group") |
| Prospectus Objective: =YCI("M:FAQIX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |